3/27
07:24 am
blco
Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting [Yahoo! Finance]
Low
Report
Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting [Yahoo! Finance]
3/27
07:00 am
blco
Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting
Low
Report
Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting
3/26
06:09 am
blco
commercetools Accelerates Global Momentum, Announces Strong 2023 Business Results [Yahoo! Finance]
Medium
Report
commercetools Accelerates Global Momentum, Announces Strong 2023 Business Results [Yahoo! Finance]
3/25
01:48 pm
blco
All You Need to Know About Bausch + Lomb (BLCO) Rating Upgrade to Buy [Yahoo! Finance]
Low
Report
All You Need to Know About Bausch + Lomb (BLCO) Rating Upgrade to Buy [Yahoo! Finance]
3/21
05:56 am
blco
Global Ophthalmic Devices, Diagnostics, and Surgical Equipment Market Forecasted to Reach $44.0 Billion by 2028 [Yahoo! Finance]
Low
Report
Global Ophthalmic Devices, Diagnostics, and Surgical Equipment Market Forecasted to Reach $44.0 Billion by 2028 [Yahoo! Finance]
3/20
02:20 pm
blco
Surging Earnings Estimates Signal Upside for Bausch + Lomb (BLCO) Stock [Yahoo! Finance]
Low
Report
Surging Earnings Estimates Signal Upside for Bausch + Lomb (BLCO) Stock [Yahoo! Finance]
3/20
09:47 am
blco
Senior Ophthalmology Executive Thomas A. (Tom) Dunlap Joins WaveFront Dynamics Inc. as an Independent Member of the Board of Directors to Support the Company's Ongoing Commercialization and Broader Strategic Initiatives [Yahoo! Finance]
Low
Report
Senior Ophthalmology Executive Thomas A. (Tom) Dunlap Joins WaveFront Dynamics Inc. as an Independent Member of the Board of Directors to Support the Company's Ongoing Commercialization and Broader Strategic Initiatives [Yahoo! Finance]
3/20
02:42 am
blco
Results from Mont Blanc Phase 3 Trial of Nicox's NCX 470 in Glaucoma Published in the American Journal of Ophthalmology [Yahoo! Finance]
Low
Report
Results from Mont Blanc Phase 3 Trial of Nicox's NCX 470 in Glaucoma Published in the American Journal of Ophthalmology [Yahoo! Finance]
3/5
01:38 am
blco
Nicox Announces Presentation of Data on NCX 470 at the 2024 American Glaucoma Society Annual Meeting [Yahoo! Finance]
Medium
Report
Nicox Announces Presentation of Data on NCX 470 at the 2024 American Glaucoma Society Annual Meeting [Yahoo! Finance]
2/28
08:14 am
blco
Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors [Yahoo! Finance]
Low
Report
Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors [Yahoo! Finance]
2/28
08:00 am
blco
Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors
Low
Report
Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors
2/28
01:36 am
blco
Nicox Appoints Experienced Biotech Executive Gavin Spencer as CEO [Yahoo! Finance]
Low
Report
Nicox Appoints Experienced Biotech Executive Gavin Spencer as CEO [Yahoo! Finance]
2/26
08:09 am
blco
Bausch + Lomb Co. (NYSE: BLCO) had its price target raised by analysts at Barclays PLC from $17.00 to $18.00. They now have an "equal weight" rating on the stock.
Medium
Report
Bausch + Lomb Co. (NYSE: BLCO) had its price target raised by analysts at Barclays PLC from $17.00 to $18.00. They now have an "equal weight" rating on the stock.
2/24
09:31 am
blco
Bausch Health: A Timely Divestiture Is The Key To An Higher Valuation [Seeking Alpha]
Low
Report
Bausch Health: A Timely Divestiture Is The Key To An Higher Valuation [Seeking Alpha]
2/24
07:53 am
blco
Bausch + Lomb Corporation (NYSE:BLCO) Yearly Results: Here's What Analysts Are Forecasting For This Year [Yahoo! Finance]
Low
Report
Bausch + Lomb Corporation (NYSE:BLCO) Yearly Results: Here's What Analysts Are Forecasting For This Year [Yahoo! Finance]
2/23
01:07 pm
blco
Bausch (BHC) Q4 Earnings and Revenues Top Estimates [Yahoo! Finance]
Low
Report
Bausch (BHC) Q4 Earnings and Revenues Top Estimates [Yahoo! Finance]
2/23
06:00 am
blco
Bausch + Lomb Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Low
Report
Bausch + Lomb Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
2/22
02:05 pm
blco
Bausch + Lomb Co. (NYSE: BLCO) had its price target lowered by analysts at Evercore Inc. from $17.00 to $16.50. They now have an "in-line" rating on the stock.
Low
Report
Bausch + Lomb Co. (NYSE: BLCO) had its price target lowered by analysts at Evercore Inc. from $17.00 to $16.50. They now have an "in-line" rating on the stock.
2/22
11:41 am
blco
Bausch + Lomb Corporation (NYSE:BLCO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Bausch + Lomb Corporation (NYSE:BLCO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/22
11:23 am
blco
Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Market to Surpass USD 44 billion by 2028 [Yahoo! Finance]
Low
Report
Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Market to Surpass USD 44 billion by 2028 [Yahoo! Finance]
2/22
10:55 am
blco
Bausch (BHC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
Low
Report
Bausch (BHC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
2/22
10:31 am
blco
Bausch + Lomb Co. (NYSE: BLCO) had its price target raised by analysts at Wells Fargo & Company from $21.00 to $23.00. They now have an "overweight" rating on the stock.
Low
Report
Bausch + Lomb Co. (NYSE: BLCO) had its price target raised by analysts at Wells Fargo & Company from $21.00 to $23.00. They now have an "overweight" rating on the stock.
2/22
07:44 am
blco
Bausch Health Companies Inc. Reports Revenue Growth Amidst Net Losses in Q4 and Full-Year 2023 [Yahoo! Finance]
Low
Report
Bausch Health Companies Inc. Reports Revenue Growth Amidst Net Losses in Q4 and Full-Year 2023 [Yahoo! Finance]
2/22
07:06 am
blco
Bausch Health Announces Fourth-Quarter and Full-Year 2023 Results [Yahoo! Finance]
Low
Report
Bausch Health Announces Fourth-Quarter and Full-Year 2023 Results [Yahoo! Finance]
2/21
01:16 pm
blco
Emergent surges 66% as it brings in Bausch + Lomb vet Papa as CEO [Seeking Alpha]
Low
Report
Emergent surges 66% as it brings in Bausch + Lomb vet Papa as CEO [Seeking Alpha]